Implication of MAPK, Lipocalin-2, and Fas in the protective action of liposomal resveratrol against isoproterenol-induced kidney injury

• 主要な著者: Ahlam M. Alhusaini (著者), Samiyah M. Alshehri (著者), Wedad S. Sarawi (著者), Hanan K. Alghibiwi (著者), Sumayya A. Alturaif (著者), Reema A. Al khbiah (著者), Shog M. Alali (著者), Shaikha M. Alsaif (著者), Ebtesam N. Alsultan (著者), Iman H. Hasan (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2024-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background and Objective: Isoproterenol (ISO) is a non-selective β-adrenergic receptor agonist. It can be used to treat bradycardia and cardiogenic shock. Despite its usefulness, the overstimulation of β-receptors by ISO can cause "cardiorenal syndrome," a term used to describe heart and k...